Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000059262) titled 'Efficacy of 12-week continuous application lipids derived from animal at two dosage levels on scalp barrier function' on Oct. 6.
Study Type: Interventional
Study Design:
Cross-over Randomized
Primary Sponsor: Pharma Foods International Co.,Ltd
Condition:
no
Intervention:
Duration: one week 0.001% lipids derived from animal Solution
Duration: one week 0.01% lipids derived from animal solution...
Recruitment Status: Not Recruiting
Phase: Not applicable
Date of First Enrollment: 2025/10/06
Target Sample Size: 13
Countries of Recruitment:
Japan
To know more, visit https://center6.umin.ac.jp/cgi...